TrkA antagonists (Pfizer)

N/A

Report date: 2025/01/26 15:39:52
NME

Base Information

Drug NameTrkA antagonists (Pfizer)
Drug Alias Nametyrosine receptor kinase A antagonists (Pfizer)TrkA antagonists (Pfizer/AstraZeneca)TRK antagonists (Neusentis)PF-06787797
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A antagonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeusentis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncAstrazeneca Plc
Inactive CompaniesNeusentis Ltd
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A